Innovations in orally disintegrating tablets for pediatric drug delivery

July 10, 2025

Remove from favorites

Add to favorites

Global regulatory demands for pediatric clinical trials have led to a marked rise in industry-driven research involving children. One of the primary challenges in this area is designing suitable drug delivery systems, made more complex by the diverse physiological and developmental stages within the pediatric population. Orally disintegrating tablets (ODTs) present a promising approach to enhance medication adherence in children. Their ability to dissolve quickly in the mouth—without the need for water—reduces the risk of choking and offers a more child-friendly alternative.

This webinar will delve into the advancing landscape of pediatric drug formulation, highlighting the growing importance of ODTs as a tailored and effective delivery system for young patients. It will examine the unique challenges of pediatric drug development, showcase emerging formulation strategies, and outline key factors to consider when creating treatments designed specifically for children.